Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Five Prime Therapeutics enters into antibody collaboration with Adimab

Jan. 10, 2014

Amunix and Janssen extend worldwide collaboration and licensing agreement

Jan. 9, 2014

Application of site-directed RNA editing to correct disease-causing genetic mutations

Jan. 9, 2014

High-throughput screening based on physiological function for novel indications of existing drugs

Jan. 8, 2014

The development of an orally available drug-loaded nanoparticle delivery system

Jan. 7, 2014

Sanofi expands access to data from clinical trials

Jan. 3, 2014

Development of a novel microfluidic biosensor for real-time in vivo monitoring of drug concentration

Dec. 27, 2013

Amarantus expands intellectual property portfolio for MANF

Dec. 24, 2013

Oxford BioMedica signs option agreement with GlaxoSmithKline

Dec. 23, 2013

NIH announces new preclinical projects under BrIDGs program

Dec. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2025.
NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 4, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...